Nancy Mortensen
Nurse Practitioner · Provo, UTNPI 1841249380
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,596 of the $5,258 with a category attached, or 68.4%. 31 manufacturers reported payments, led by Novartis at 29.7% of the total. 2025 is the largest year on record at $2,862, more than ten times the $226 reported in 2021. Among nurse practitioner clinicians in UT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 195 payments — averaging $26.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$2K
- Daiichi Sankyo Inc.$457
- AstraZeneca$376
- Merck$332
- Pfizer$301
- Seagen Inc.$272
- plus $2K from 25 others
What the payments were for
- Food & beverage$3,59668%
- Education$2996%
- Other$1,36326%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 25 | $1,563 |
| Daiichi Sankyo Inc. | 26 | $457 |
| AstraZeneca | 16 | $376 |
| Merck | 14 | $332 |
| Pfizer | 19 | $301 |
| Seagen Inc. | 6 | $272 |
| GSK | 9 | $222 |
| Johnson & Johnson | 9 | $203 |
| Incyte Corporation | 6 | $188 |
| Eisai Inc. | 8 | $144 |
| Sanofi | 6 | $130 |
| Puma Biotechnology, Inc. | 6 | $130 |
| Array Biopharma Inc | 9 | $116 |
| EMD Serono, Inc. | 4 | $103 |
| AbbVie | 4 | $89 |
| Karyopharm Therapeutics Inc. | 2 | $80 |
| Jazz Pharmaceuticals Inc. | 4 | $68 |
| Genmab U.S., Inc. | 3 | $65 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $51 |
| E.r. Squibb & Sons, L.L.C. | 3 | $51 |
| Tersera Therapeutics LLC | 2 | $46 |
| Lilly USA, LLC | 2 | $40 |
| Bristol Myers Squibb | 2 | $38 |
| Genentech USA, Inc. | 1 | $34 |
| Boston Scientific | 1 | $27 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $25 |
| Coherus Oncology, Inc. | 1 | $24 |
| Legend Biotech USA Inc. | 1 | $23 |
| Regeneron Healthcare Solutions, Inc. | 1 | $20 |
| Fennec Pharmaceuticals, Inc. | 1 | $19 |
| Pharmaessentia USA Corporation | 1 | $19 |
How this compares
$5,258 in reported general payments places this provider in the 95th percentile of 979 nurse practitioner providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 19 | $10,320 |
| Anastrozole | 54 | $1,325 |
| Tamoxifen Citrate | 13 | $438 |
| Letrozole | 17 | $418 |
| Dexamethasone | 12 | $347 |
| Potassium Chloride | 15 | $205 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 11 | $185 |
| Prochlorperazine Maleate | 11 | $142 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $203 | $10,32019 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 979 nurse practitioner providers in Utah.
Other nurse practitioner in Provo
- Clarene HansenProvo$11K
- Steven LarsenProvo$11K
- James BiesingerProvo$11K
- Tracy WilliamsProvo$9K
- Valerie JuarezProvo$7K
- April JensenProvo$5K
- Ann RogersonProvo$4K
- Nancy TrotterProvo$4K
- David GambleAmerican Fork$836K
- Julia BattenSalt Lake City$223K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.